Tampa General Hospital (TGH) today announced that Dr. Boris Naraev, a medical oncologist specializing in caring for patients living with gastrointestinal, neuroendocrine and endocrine tumors, has ...

A revolutionary new treatment called Targeted Thermal Therapy (Tripel T) offers a safer, faster alternative to surgery for patients with high blood pressure caused by Primary Aldosteronism, a hormonal ...

Adrenal tumors are a heterogeneous group of tumors characterized by diverse biology and clinical courses. They may be associated with high malignant potential and/or hormonal activity, leading to ...

A brain tumor is a mass of abnormal cells that grow in the brain. Brain tumors can be benign (non-cancerous) or malignant (cancerous) and can start anywhere in the brain. Malignant tumors grow rapidly ...

eAArly DETECT 2 feasibility study designed to validate earlier results on advanced adenomas over a large population of average risk patients Multi-center study expected to complete enrollment in ...

When a child develops a brain tumor, early diagnosis is essential. Alan Cohen, M.D., director of pediatric neurosurgery at Johns Hopkins Children’s Center, shares the most common signs and symptoms ...

All but one of the patients saw their tumors shrink or stop growing after receiving infusions once a week for eight to 12 weeks. Scientists also tested the therapy on five monkeys with liver ...

The tissue adjacent to a tumor behaves differently than areas farther away: The tumor’s cancerous cells influence their surroundings, blocking the body’s immune defenses and creating a sort of haven ...

Brain cancer and other nervous system cancers have a 33.4% five-year survival rate. In adults, brain tumors rarely begin in the brain — when they do, they're known as primary brain cancers.

For 3 out of every hundred people with cancer, the primary site of cancer isn't found. When this is the case, the tumor is usually referred to as a metastatic cancer of unknown primary origin. With ...

Chimeric antigen receptor-T (CAR-T) cell therapy, initially successful in hematologic malignancies, presents a promising avenue for treating solid tumors, including CRC. This review explores the ...